ADC Therapeutics SA (ADCT) is a biotechnology company listed on NYSE.
Latest reported ADCT revenue for 2026-06-30 was $40.1M. Net income was -$49.5M. Revenue was up 92.3% from 2026-03-31 to 2026-06-30. ADCT currently screens at market cap $141.2M.
Use this ADCT page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the ADCT quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the ADCT SEC filings page. Lician reads the product cache first so this HTML stays unique to ADC Therapeutics SA even when a live quote feed is slow.
Latest cached year on this hub. Full ADCT income, balance, and cash tables.